Evolus, Inc. Common Stock

EOLS

$6.26

Name : Evolus, Inc. Common Stock

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $404,930,752.00

EPSttm : -0.97

Evolus, Inc. Common Stock

$6.26

2.64%

$0.17

Float Short %

22.92

Margin Of Safety %

Put/Call OI Ratio

0.61

EPS Next Q Diff

0.37

EPS Last/This Y

0.26

EPS This/Next Y

0.69

Price

6.26

Target Price

18.83

Analyst Recom

1.29

Performance Q

-35.2

Relative Volume

0.8

Beta

0.97

Ticker: EOLS

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	EOLS	7.62	1.27	0.37	18939
2025-09-09	EOLS	7.41	1.25	0.50	19071
2025-09-10	EOLS	7.35	1.25	0.01	19075
2025-09-11	EOLS	7.51	1.25	0.04	19040
2025-09-12	EOLS	7.2	1.25	0.01	19089
2025-09-15	EOLS	6.63	1.22	0.83	19253
2025-09-16	EOLS	6.51	1.22	0.02	19279
2025-09-17	EOLS	6.52	1.168378050127	0.018518518518519	19639
2025-09-18	EOLS	6.41	1.14	0.00	19635
2025-09-22	EOLS	6.31	1.20	0.57	19205
2025-09-23	EOLS	6.2	0.63	0.00	14238
2025-09-24	EOLS	6.08	0.63	1.25	14240
2025-09-25	EOLS	5.97	0.63	0.57	14250
2025-09-26	EOLS	6.03	0.63	1.00	14595
2025-09-29	EOLS	6.15	0.63	0.14	14619
2025-09-30	EOLS	6.1	0.63	0.00	14672
2025-10-01	EOLS	6.15	0.63	0.00	14676
2025-10-02	EOLS	6.24	0.62	0.00	14680
2025-10-03	EOLS	6.49	0.62	0.05	14809
2025-10-06	EOLS	6.43	0.61	0.00	14944
2025-10-07	EOLS	6.26	0.61	0.30	14911
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	EOLS	7.61	12.3	62.2	-0.55
2025-09-09	EOLS	7.41	12.3	61.8	-0.55
2025-09-10	EOLS	7.34	12.3	62.2	-0.55
2025-09-11	EOLS	7.51	12.3	62.7	-0.55
2025-09-12	EOLS	7.20	12.3	61.6	-0.55
2025-09-15	EOLS	6.62	12.3	60.9	-0.55
2025-09-16	EOLS	6.52	12.3	62.0	-0.55
2025-09-17	EOLS	6.53	12.3	62.3	-0.55
2025-09-18	EOLS	6.41	12.3	62.0	-0.55
2025-09-19	EOLS	6.27	12.3	61.9	-0.55
2025-09-22	EOLS	6.31	12.3	62.4	-0.55
2025-09-23	EOLS	6.20	12.3	62.0	-0.55
2025-09-24	EOLS	6.08	12.3	62.0	-0.55
2025-09-25	EOLS	5.98	12.3	62.0	-0.55
2025-09-26	EOLS	5.99	12.3	62.3	-0.55
2025-09-29	EOLS	6.15	12.3	62.8	-0.55
2025-09-30	EOLS	6.15	12.3	62.4	-0.55
2025-10-01	EOLS	6.14	12.3	62.3	-0.55
2025-10-02	EOLS	6.24	12.3	62.6	-0.55
2025-10-03	EOLS	6.50	12.3	63.1	-0.55
2025-10-06	EOLS	6.43	12.3	62.9	-0.55
2025-10-07	EOLS	6.26	12.3	61.8	-0.55
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	EOLS	-1.93	9.35	21.02
2025-09-09	EOLS	-1.93	9.35	21.02
2025-09-10	EOLS	-1.93	9.35	21.02
2025-09-11	EOLS	-1.93	9.35	22.89
2025-09-12	EOLS	-1.93	9.35	22.89
2025-09-15	EOLS	-1.84	9.27	22.89
2025-09-16	EOLS	-1.84	9.27	22.89
2025-09-17	EOLS	-1.84	9.27	22.89
2025-09-18	EOLS	-1.84	9.27	22.89
2025-09-19	EOLS	-1.84	9.27	22.89
2025-09-22	EOLS	-0.83	9.27	22.86
2025-09-23	EOLS	-0.83	9.27	22.86
2025-09-24	EOLS	-0.83	9.27	22.86
2025-09-25	EOLS	-0.83	9.27	22.92
2025-09-26	EOLS	-0.83	9.27	22.92
2025-09-29	EOLS	-0.79	9.27	22.92
2025-09-30	EOLS	-0.79	9.27	22.92
2025-10-01	EOLS	-0.79	9.27	22.92
2025-10-02	EOLS	-0.79	9.27	22.92
2025-10-03	EOLS	-0.79	9.27	22.92
2025-10-06	EOLS	-0.79	5.26	22.92
2025-10-07	EOLS	-0.79	5.26	22.92
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.3

Avg. EPS Est. Current Quarter

-0.16

Avg. EPS Est. Next Quarter

0.07

Insider Transactions

-0.79

Institutional Transactions

5.26

Beta

0.97

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

64.9

Max Drawdown 5-Year %

-68.4

Target Price

18.83

P/E

Forward P/E

PEG

P/S

1.46

P/B

P/Free Cash Flow

EPS

-0.97

Average EPS Est. Cur. Y

-0.55

EPS Next Y. (Est.)

0.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-22.31

Relative Volume

0.8

Return on Equity vs Sector %

307.2

Return on Equity vs Industry %

324.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

61.8

Evolus, Inc. Common Stock

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 394

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

stock quote shares EOLS – Evolus, Inc. Stock Price stock today

news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch EOLS – Evolus, Inc. yahoo finance google finance

stock history EOLS – Evolus, Inc. invest stock market

stock prices EOLS premarket after hours

ticker EOLS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EOLS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y